Diligence memo · auto-generated · as of July 2, 2026

Companion Diagnostics, Inc.

Companion Diagnostics, Inc. looks under-valued against its niche peers and is active on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

Companion Diagnostics, Inc. operates in Other Health Care, based in INDIANAPOLIS.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Companion Diagnostics, Inc. has raised $1.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $1.0M on —.

Valuation (modeled)modeled

Provath models Companion Diagnostics, Inc. at approximately $1.6M (range $627K–$2.9M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.25× the median modeled value of Pre-Seed Other Health Care companies (2036 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

No dated round to assess.

Comparablesmixed

Capital scale ranks ahead of 35% of Other Health Care peers (5377 compared).

Modeled value ranks above 8% of those peers.

Peoplefiled

5 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.